
HTGF et al. invest €500,000 in Microstim
High-Tech Gründerfonds (HTGF), HCS Beteiligungsgesellschaft, Fides Finanz-Invest and Genius Venture Capital have backed Microstim, a medical devices company, with €500,000.
The fresh capital will be used to apply for European CE approval and the first clinical application of Microstim's muscle stimulator.
Genius Venture invested via its Technologiefonds MV fund, a €6m vehicle that closed in April 2009.
Previous funding
HTGF initially invested €500,000 in Microstim in 2009, backing the firm's preparation to enter the clinical trial phase with its muscle stimulator in early 2010.
In 2011, HTGF, Genius Venture and Fides Finanz-Invest injected €1.5m to develop the stimulator further.
Company
Microstim is based in Wismar and was founded in 2007. The company primarly develops tissue-maintaining and function-preserving implantable muscle stimulators for muscle-powered cardiac assistance.
People
Christian Semmler is managing director of HCS. Norbert W Guldner is cardiac surgeon and researcher at Microstim. Peter Klapproth is co-founder and managing director of Microstim.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater